Seelaus Asset Management LLC Amgen Inc Transaction History

Seelaus Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$221.91 - $258.6 $479,547 - $558,834	-2,161 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $693,714 - $826,090	-3,206 Reduced 59.74%	2,161 $497,000
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $254,829 - $283,391	-1,086 Reduced 16.83%	5,367 $1.36 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $51,826 - $63,597	-262 Reduced 3.9%	6,453 $1.52 Million
Q1 2020 May 04, 2020	SELL	$182.24 - $241.7 $6,013 - $7,976	-33 Reduced 0.49%	6,715 $1.36 Million
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $98,389 - $126,464	-520 Reduced 7.15%	6,748 $1.63 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $57,804 - $69,261	-332 Reduced 4.37%	7,268 $1.41 Million
Q2 2019 Jul 31, 2019	BUY	$166.7 - $195.41 $624,624 - $732,201	3,747 Added 97.25%	7,600 $1.4 Million
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $487,806 - $549,864	-2,697 Reduced 41.18%	3,853 $732,000
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $1.17 Million - $1.36 Million	6,550 New	6,550 $1.28 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Seelaus Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Seelaus Asset Management LLC with notifications on news.